Thus, the pleiotrophic effects of chronically elevated IL-6 levels preclude any obvious usefulness in treating obesity or its associated metabolic complications in man, despite the fact that weight reduction may be expected [82]. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.